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The clathrin assembly lymphoid myeloid leukemia (CALM) gene encodes a putative homologue of the
clathrin assembly synaptic protein AP180. Hence the biochemical properties, the subcellular localiza-
tion, and the role in endocytosis of a CALM protein were studied. In vitro binding and coimmuno-
precipitation demonstrated that the clathrin heavy chain is the major binding partner of CALM. The
bulk of cellular CALM was associated with the membrane fractions of the cell and localized to
clathrin-coated areas of the plasma membrane. In the membrane fraction, CALM was present at near
stoichiometric amounts relative to clathrin. To perform structure–function analysis of CALM, we
engineered chimeric fusion proteins of CALM and its fragments with the green fluorescent protein
(GFP). GFP–CALM was targeted to the plasma membrane–coated pits and also found colocalized
with clathrin in the Golgi area. High levels of expression of GFP–CALM or its fragments with
clathrin-binding activity inhibited the endocytosis of transferrin and epidermal growth factor recep-
tors and altered the steady-state distribution of the mannose-6-phosphate receptor in the cell. In
addition, GFP–CALM overexpression caused the loss of clathrin accumulation in the trans-Golgi
network area, whereas the localization of the clathrin adaptor protein complex 1 in the trans-Golgi
network remained unaffected. The ability of the GFP-tagged fragments of CALM to affect clathrin-
mediated processes correlated with the targeting of the fragments to clathrin-coated areas and their
clathrin-binding capacities. Clathrin–CALM interaction seems to be regulated by multiple contact
interfaces. The C-terminal part of CALM binds clathrin heavy chain, although the full-length protein
exhibited maximal ability for interaction. Altogether, the data suggest that CALM is an important
component of coated pit internalization machinery, possibly involved in the regulation of clathrin
recruitment to the membrane and/or the formation of the coated pit.
INTRODUCTION
Clathrin-mediated vesicle formation is an essential step in
endocytosis and the intracellular trafficking of macromole-
cules. Clathrin-coated pits located at the plasma membrane
and the trans-Golgi network (TGN) serve to form transport
vesicles destined to various endosomal compartments (re-
viewed in Schmid, 1997; Traub and Kornfeld, 1997). Clathrin
coats are also found on endosomes (Stoorvogel et al., 1996).
However, the role of these coats is not defined. The major
structural components of clathrin-coated pits are the clathrin
triskelions and the clathrin adaptor protein complexes or
APs. Each AP is a heterotetramer consisting of two large,
one medium, and one small subunit (reviewed in Robinson,
1997). AP-2 functions at the plasma membrane, and AP-1
functions at the TGN. Another tetrameric protein complex,
AP-3, is found in endosomes in mammalian cells (reviewed
in Odorizzi et al., 1998); however the function of AP-3 and
whether it participates in clathrin coats are under debate.
Besides structural elements of the coat, a growing number
of proteins associated with clathrin-coated pits and vesicles
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are being identified. These proteins participate in multiple
protein–protein interactions and enzymatic activities that
control the dynamic cycle of coat assembly and disassembly.
This cycle begins with the attachment of APs and, subse-
quently, clathrin triskelions to the membrane leading to the
formation of a polyhedral lattice, continues during recruit-
ment of cargo proteins, coat invagination, and vesicle scis-
sion, and ends with the release of the coat elements from the
vesicle to the cytosol followed by their recycling back to the
donor membrane.
One of the major components of brain clathrin-coated
vesicles is AP180 (also known as AP-3, NP185, pp155, Fl-20)
(Ahle and Ungewickell, 1986; Keen and Black, 1986; Kohtz
and Puszkin, 1988; Lindner and Ungewickell, 1992; Zhou et
al., 1992). AP180 is located in clathrin-coated buds in the
nerve terminal plasma membrane (Takei et al., 1996). AP180
is capable of binding to clathrin triskelions and cages and of
promoting the assembly of clathrin coats in vitro (Lindner
and Ungewickell, 1992; Ye and Lafer, 1995a,b). Both N- and
C-terminal regions of AP180 have the ability to bind clathrin
triskelions, although only the C-terminal part promotes coat
assembly and binds to clathrin cages (Ye and Lafer, 1995a,b).
AP180 also binds phosphoinosides and inositolphosphates
via its N-terminal domain (Norris et al., 1995; Ye et al., 1995;
Hao et al., 1997). Despite extensive biochemical characteriza-
tion of AP180, almost no information is available regarding
the function of AP180 in vivo.
Yeast homologues of AP180 have been identified, and
their binding to clathrin has been demonstrated (Wendland
and Emr, 1998). The deletion of yeast AP180 genes had no
significant effect on endocytosis (Wendland and Emr, 1998).
Recently, the Drosophila homologue of AP180 (LAP) has
been cloned (Zhang et al., 1998). A mutation that eliminates
LAP severely impairs synaptic vesicle endocytosis and alters
the normal localization of clathrin in nerve terminals. Most
importantly, the size of synaptic vesicles is significantly
increased in lap mutants.
Recently a human gene that displayed substantial se-
quence similarity to rat AP180 was found to be involved in
the t(10;11) chromosomal translocation, a rare translocation
found in lymphoid as well as in myeloid acute leukemias,
and was named CALM for the clathrin assembly lymphoid
myeloid leukemia gene (Dreyling et al., 1996). CALM tran-
scripts were detected in all tissues tested, and therefore it
was proposed that CALM is a nonneuronal homologue of
AP180. The properties of the CALM protein have not been
characterized.
In this study the molecular interactions and subcellular
localization of the CALM protein were investigated. The
data demonstrate that clathrin is the major binding partner
of CALM. Overexpression of clathrin-binding fragments of
CALM dramatically affects clathrin-mediated endocytosis
and the trafficking of receptors between the TGN and endo-
somes. The data suggest an important role for CALM in the
regulation of clathrin internalization machinery.
MATERIALS AND METHODS
Reagents
Iron-saturated transferrin conjugated with Texas Red (TRF–TR) was
purchased from Molecular Probes (Eugene, OR). Human recombi-
nant epidermal growth factor (EGF) was obtained from Collabora-
tive Research (Bedford, MA). Mouse receptor-grade EGF was iodin-
ated using a modified chloramine T method as described previously
(Carpenter and Cohen, 1976). The specific activity of 125I-labeled
EGF was 1.5–1.9 3 105 cpm/ng. A polyclonal antibody to the
cation-independent mannose-6-phosphate (M6P) receptor is a gift of
Dr. L. Macovcik (Yale University, New Haven, CT). Monoclonal
antibodies to the clathrin heavy chain (X.22 and TD.1) and the
a-subunits of AP-2 (AP.6) (Brodsky, 1985) were obtained from
American Type Culture Collection (Rockville, MD), whereas the
monoclonal 100/3 specific to g-adaptin was from Sigma (St. Louis,
MO). AC1-M11 antibody was purchased from Affinity Bioreagents
(Golden, CO). Polyclonal antibodies were either used as the immu-
noglobulin G (IgG) fraction purified from serum using Protein
A-Sepharose (Sigma) or affinity-purified. Rabbit antibody to CALM
was raised to the purified N-terminal fragment of CALM (residues
1–413) obtained by proteolytic digestion of the glutathione-S-trans-
ferase (GST)–1–413 fragment of CALM and affinity-purified using
this fragment covalently immobilized on CNBr-Sepharose.
Cloning of the CALM Expression Constructs
DNA encoding CALM full-length cDNA and its fragments cor-
responding to residues 1–413 and 414–652 were obtained by PCR
using CALM cDNA (Dreyling et al., 1996). Primers were designed to
express CALM as N-terminal fusion proteins with GST in the pGEX-
5X-1 vector (Pharmacia, Piscataway, NJ) using BamHI and NotI
restriction sites.
A bright green fluorescence mutant of green fluorescent protein
(GFP), enhanced GFP (Clontech, Palo Alto, CA), was attached to the
N or C terminus of full-length CALM or its fragments by standard
recombinant PCR techniques. Primers containing BglII (forward) or
KpnI (backward) restriction sites were designed to clone full-length
CALM (amino acid residues 1–652) and N-terminal (residues 1–413,
1–304) or C-terminal (residues 414–652) fragments. These were
cloned into the pEGFP-C1 to produce GFP–CALM, GFP–1–413,
GFP–1–304, and GFP–414–652, respectively, and into pEGFP-N1 to
produce CALM–GFP, 1–414–GFP, and 1–303–GFP. Backward prim-
ers containing a stop codon were designed to clone full-length
CALM and fragments 1–413 and 1–304 into pEGFP-N1 to obtain
constructs encoding untagged proteins. To clone GFP–1–613 and
GFP–414–613 fusion proteins, we digested GFP–CALM and GFP–
414–652 with BglII and EcoRI (internal site), and the liberated frag-
ments 1–613 and 414–613 were cloned into BglII/EcoRI sites of
pEGFP-C1. To create GFP–613–652, we digested GFP–CALM with
BglII and EcoRI (internal site) to remove fragment 1–612, and the
sticky ends were blunted by end filling and ligated together.
Metabolic Cell Labeling and Protein–Protein
Interactions
HeLa cells were incubated with 35S-TransLabel (ICN Biochemicals,
Costa Mesa, CA) overnight in methionine-free media and 1% dia-
lyzed serum. The cells were washed with Ca21- and Mg21-free
phosphate-buffered saline (CMF-PBS) and then permeabilized using
buffer A (150 mM KCl, 2 mM MgCl2, 20 mM HEPES, 10% glycerol,
pH 7.2, 1 mM dithiothreitol, 1 mM EGTA, 1 mM EDTA, 1 mM
sodium orthovanadate, 10 mM sodium fluoride, 1 mM phenylmeth-
ylsulfonyl fluoride, 10 mg/ml leupeptin, 544 mM iodoacetamide, 10
mg/ml aprotinin) supplemented with 0.02% saponin by scraping
from the dish with a rubber policeman and incubated for 15 min at
4°C to allow the release of the cytosolic proteins. The saponin
(cytosolic) fraction was then centrifuged at 14,000 3 g for 10 min.
The membrane fractions were solubilized with buffer A supple-
mented with 1% Triton X-100 (TX100) and 1% sodium deoxycholate.
GST–CALM, GST–1–413, or GST–414–652 immobilized on glu-
tathione-agarose beads was incubated with the cytosol or mem-
brane fractions of the [35S]methionine-labeled cells for 3 h at 4°C.
After extensive washes of the beads with buffer A, the beads were
heated at 90°C for 5 min in sample buffer, the bound proteins were
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resolved on 7.5% SDS-PAGE, and proteins were transferred to
nitrocellulose membranes and analyzed by autoradiography and
Western blotting (Sorkin et al., 1996).
Cell Culture and Transfections
HeLa cells were grown in DMEM containing 10% fetal bovine
serum, gentamycin, and glutamine. COS-1 cells were grown in
DMEM containing 10% newborn calf serum, antibiotics, and glu-
tamine. Cells grown to 50–80% confluency were transfected with
pEGFP-CALM DNAs using lipofectamine (Life Technologies,
Gaithersburg, MD) or Effectene (Qiagen, Hilden, Germany). Tran-
sient transfections were used for all experiments with COS-1 and
HeLa cells. The number of transfected cells, estimated by GFP
fluorescence, varied from 30 to 70% in different experiments. Trans-
fected cells were split 1 d after transfection to dishes and glass
coverslips and used for experiments on the second or third day.
Cells were grown to ;90 or 50% confluency for coimmunoprecipi-
tation or immunofluorescence experiments, respectively.
Immunoprecipitation and Western Blotting
Cells grown on 35-mm dishes were washed with CMF-PBS and
solubilized by scraping with a rubber policeman in buffer A con-
taining 1% TX100 and by incubating further for 10 min at 4°C.
Lysates were then centrifuged at 14,000 3 g for 10 min. Superna-
tants were incubated with rabbit Ab20 specific to CALM, rabbit
anti-GFP (Clontech), or monoclonal antibody X.22 to clathrin heavy
chain (CHC) for 3–15 h at 4°C and then 30–60 min after the addition
of Protein A-Sepharose (Sigma) or Protein G-Sepharose (Zymed,
San Francisco, CA), respectively. Normal rabbit or mouse IgG
(Zymed) were used as a nonspecific control.
Immunoprecipitates were washed twice with buffer A containing
TX100 supplemented with 100 mM NaCl and then once without
NaCl. Proteins were separated on 7.5% SDS-PAGE, transferred to
nitrocellulose membranes, and immunoblotted as described above.
The nitrocellulose membranes were probed with Ab20, TD.1 specific
to CHC, and monoclonal or polyclonal anti-GFP. To detect primary
mouse or rabbit antibodies, sheep anti-mouse IgG (Cappel, West
Chester, PA) or Protein A (Zymed) conjugated with horseradish
peroxidase were used, respectively. Enhanced chemiluminescence
(Pierce Chemical, Rockford, IL) was used for detection of the horse-
radish peroxidase reaction.
Cell Fractionation
Cells were mildly permeabilized by scraping from the dish with a
rubber policeman in buffer A containing 0.02% saponin and incu-
bated for 15 min at 4°C to allow the release of the cytosolic proteins.
The saponin (cytosolic) fraction was then centrifuged at 14,000 3 g
for 10 min. This centrifugation was sufficient to pellet the saponin-
permeabilized cells without the loss of membranes, demonstrated
by the lack of detectable receptors for EGF in the supernatant. The
high-speed centrifugation of saponin-permeabilized cells at
100,000 3 g for 20 min instead of 14,000 3 g did not change the
distribution of CALM and clathrin between cellular fractions.
The pellet of saponin-permeabilized cells was broken by pipetting
in buffer A containing 1% TX100 and incubated further for 10 min at
4°C. The TX100 lysates were centrifuged at 14,000 3 g for 10 min to
obtain a TX100-soluble fraction, and the pellets were solubilized in
preheated SDS sample buffer followed by sonication to obtain a
TX100-insoluble fraction. Several different aliquots of the saponin
and TX100-soluble and -insoluble fractions were processed for elec-
trophoresis and Western blot analysis to detect CHC (antibody
TD.1), CALM (Ab20), a-adaptins (antibody AC1-M11), and g-adap-
tin (antibody 100/3).
As the protein standard in Western blot detection of CHC, the
GST-fused N-terminal fragment of CHC corresponding to residues
1–579 (GST–TD, the fragment recognized by TD.1) was used. The
plasmid was kindly provided by Dr. J. Keen (Thomas Jefferson
University, Philadelphia, PA). In each experiment, various amounts
of GST–TD and the fragment 1–413 of CALM (recognized by Ab20)
obtained by removing the GST moiety from GST–1–413 were pro-
cessed by SDS-PAGE and Western blotting. The concentrations of
the recombinant proteins were determined by measuring the UV
absorbance at 280 nm and using the molar extinction coefficient eM
values at 280 nm of 18,670 M21cm21 and 89,110 M21cm21 for CALM
fragment 1–413 and GST–TD, respectively, which were calculated
according to Gill and von Hippel (1989). All stages of the Western
blotting and the chemiluminescence detection of the recombinant
protein standards and cellular fractions were performed simulta-
neously in the same solutions. The amount of protein was quanti-
tated using densitometry of several films obtained after various
lengths of exposure times with the same blot and analyzed using a
Molecular Analyst software (Bio-Rad, Richmond, CA). The calibra-
tion curves were built in each experiment, and the concentrations of
the proteins in cellular fractions were determined by interpolation
from the calibration curves within the linear range of immunoblot-
ting detection. The molar amounts of CHC and CALM in the
cellular fractions were then calculated.
Endocytosis of Transferrin
Transfected cells grown on coverslips were incubated for 30 min in
binding medium (DMEM, 0.1% bovine serum albumin) to deplete
the transferrin present in serum and then incubated with 5 mg/ml
TRF–TR for 10–15 min at 37°C. Cells were then washed with CMF-
PBS and fixed with paraformaldehyde. The fixed cells were either
mounted for microscopy or permeabilized and processed for im-
munofluorescence staining as described below.
The effect of CALM expression on TRF–TR endocytosis was quan-
titated by analyzing several hundred cells in each preparation. The
number of cells with or without significant accumulation of TRF–TR
was scored in two groups of the cells: 1) cells that express a high
amount of a GFP fusion protein but preserve normal cell morphol-
ogy and 2) cells that express a low or moderate amount of or no GFP
fusion proteins. The effect on endocytosis was expressed as the
percent of cells without TRF–TR of the total number of cells of each
group.
Immunofluorescence Staining
For staining with Ab20, cells grown on coverslips were washed with
CMF-PBS and fixed in methanol at 220°C for 5 min. In experiments
in which costaining of Ab20 and AP.6 or 100/3 was performed, the
methanol fixation was followed by the incubation of fixed cells with
acetone for 5 min at 220°C. To examine the localization of proteins
in TX100-treated cells, we incubated cells grown on coverslips with
0.02% saponin in buffer A for 15 min at 4°C and then with 1% TX100
in buffer A for 10 min at 4°C. After the rinse with CMF-PBS, the
permeabilized cells were fixed with methanol/acetone. Cells ex-
pressing GFP fusion proteins were fixed with freshly prepared 4%
paraformaldehyde (Electron Microscopy Sciences, Fort Washington,
PA) for 12 min at room temperature and mildly permeabilized
using a 3-min incubation in CMF-PBS containing 0.1% TX100 and
0.1% BSA at room temperature.
Coverslips with cells fixed with methanol or formaldehyde were
then incubated in CMF-PBS containing 1% BSA at room tempera-
ture for 1 h with the primary antibody, washed intensively, and
then incubated with the secondary donkey anti-mouse IgG labeled
with Texas Red (Jackson ImmunoResearch, West Grove, PA). Both
primary and secondary antibody solutions were precleared by cen-
trifugation at 100,000 3 g for 10 min. For triple-label fluorescence
experiments, TRF–TR and GFP fluorescence was visualized simul-
taneously with anti-clathrin X.22 detected with the secondary anti-
body labeled with 7-amino-4-methylcoumarin-3-acetic acid
(AMCA; emission at 450 nm; Jackson ImmunoResearch). After
staining, the coverslips were mounted in Fluoromount-G (Fisher
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Scientific, Pittsburgh, PA) containing 1 mg/ml para-phenylenedia-
mine.
The samples were analyzed using digital deconvolution micros-
copy. A Nikon (Garden City, NY) Diaphot 300 microscope equipped
with a 100 3 1.4 numerical aperture oil immersion objective lens
and the single fluorochrome filter sets for either Texas Red, fluores-
cein, or AMCA/DAPI (Chroma, Brattleboro, VT) were used for
visualization and recording of the images. To obtain high-resolution
three-dimensional images of cells, an imaging workstation consist-
ing of the thermoelectrically cooled charged-coupled device Micro-
max camera with the Sony Interline area array (Princeton Instru-
ments, Trenton, NJ), the Nikon Diaphot microscope equipped with
a z-step motor, and the dual filter wheel controlled by QED Imaging
or Intelligent Imaging Innovation (3I, Denver, CO) software was
used. Typically, 15–40 serial two-dimensional images were re-
corded at 100- to 200-nm intervals. A Z-stack of images obtained
was deconvoluted using a modification of the constrained iteration
method on a DeltaVision workstation (Applied Precision, Issaquah,
WA) or using 3I software. The final arrangement of images was
performed using Adobe Photoshop 4.03.
Living Cell Fluorescence Imaging of GFP
COS-1 cells transiently expressing GFP fusion proteins were grown
in glass chambers (Bioptechs, Butler, PA). The chamber was
mounted onto the microscope stage, and the image acquisition
through the narrow GFP (excitation 492/10 nm) channel was
started. Typically, 50–100 images were acquired every 1–2 s (0.3 s
exposure) at room temperature using the QED Imaging workstation
as described for immunofluorescence experiments. Binning 2 3 2 or
“no binning” modes were used.
Internalization of 125I-labeled EGF
To monitor 125I-labeled EGF internalization, COS-1 cells grown in
12-well dishes were incubated with 125I-labeled EGF in binding
medium at 37°C for 1–10 min. The concentration of 125I-labeled EGF
was 2 ng/ml to avoid saturation of the internalization machinery.
After the indicated times, the medium was aspirated, and the mono-
layers were rapidly washed three times with DMEM to remove
unbound ligand. The cells were then incubated for 5 min with 0.2 M
acetic acid, pH 2.8, containing 0.5 M NaCl at 4°C. The acid wash was
combined with another short rinse in the same buffer and used to
determine the amount of surface-bound 125I-labeled EGF. Finally
the cells were lysed in 1 M NaOH to determine the internalized
radioactivity. The ratio of internalized to surface radioactivity was
plotted against time. The linear regression coefficient of the depen-
dence of this ratio for time represents the specific rate constant for
internalization. Nonspecific binding was measured for each time
point in the presence of a 100-fold molar excess of unlabeled EGF
and was not .3–5% of the total counts.
RESULTS
Identification of CALM Protein and Its Interaction
with Clathrin
To identify the product of the CALM gene, we purified the
GST fusion protein of the N-terminal fragment of CALM
(1–413), cleaved the GST moiety, and used the fragment to
raise a polyclonal antibody, Ab20. The recognition site of the
antibody is between residues 304 and 413 because Ab20 did
not recognize the fragment corresponding to residues 1–303.
Western analysis with affinity-purified Ab20 detected two
specific bands of 72 and 66 kDa in lysates of human HeLa
and monkey COS-1 cells (Figure 1A). The size of the larger
band agrees well with the predicted molecular mass of
full-length CALM of 71.5 kDa. The recombinant CALM
transiently expressed in COS-1 cells has the same mobility
on SDS-PAGE as the slow-migrating form of endogenous
CALM (Figure 1A). Both forms of endogenous CALM could
be detected in the immunoprecipitates of Ab20 (Figure 1B).
The specificity of Ab20 was also confirmed by immunopre-
cipitation of recombinant CALM cloned as a fusion protein
with the GFP and transiently expressed in HeLa cells (Figure
1C). In the Western blotting assay, Ab20 specifically recog-
nized GFP–CALM precipitated with anti-GFP (Figure 1C).
CALM was detected in all cell lines tested as well as in
bovine brain lysates and coated vesicles isolated from bo-
vine brain. Whereas more of the larger form of CALM was
expressed in HeLa cells, the smaller form was predominant
in COS-1 (Figure 1A), NIH 3T3, and several other cell types
(our unpublished data). It is possible that the smaller form is
a proteolytic product or an alternative-splicing variant. The
differential expression supports the latter possibility. In fact,
two alternatively spliced forms of human CALM with an
internal deletion of 7 or 50 amino acid residues were re-
ported previously (Dreyling et al., 1996) (Figure 2). The
“short” form of human CALM (lacking 49 residues) may
correspond to a 66-kDa species of CALM detected by Ab20.
Western blot analysis shows that CALM does not display
an abnormally slow mobility on SDS-PAGE that is observed
for AP180 (Murphy et al., 1991). The sequence comparison of
human CALM and AP180 molecules reveals that CALM
displays significant sequence identity to AP180 in the N-
terminal part of the molecule (1–300) and in several stretches
of the C-terminal domain (Figure 2). The slow mobility of
AP180 is presumably caused by the acidic region between
residues 305 and 360 (Murphy et al., 1991) that is absent in
CALM.
On the basis of the sequence similarity of CALM and
AP180, it can be anticipated that CALM would bind clathrin
and localize to clathrin-coated pits. As expected, a substan-
tial amount of CHC immunoreactivity was detected in
CALM immunoprecipitates from TX100 lysates of HeLa
cells (Figure 1B). The immunoprecipitation of GFP–CALM
expressed in HeLa cells by anti-GFP also brings down CHC
(Figure 1C).
Immunofluorescence staining of HeLa cells with Ab20
required methanol fixation and revealed a punctate pattern
of staining typical of clathrin-coated pits (Figure 3). There
was also nonspecific staining of cell nuclei as commonly
seen in methanol-fixed cells labeled with any rabbit IgG.
Double-label immunofluorescence and digital deconvolu-
tion of three-dimensional images reveal significant colocal-
ization of CALM and clathrin immunoreactivities, although
some dots were stained only with antibodies to clathrin or
CALM (Figure 3, A–C). There are two major sites of clathrin
localization in the cell: coated buds at the plasma membrane
and in TGN containing AP-2 and AP-1, respectively. There-
fore, we tested which subset of coats contains CALM. Figure
3, D–F, shows almost complete colocalization of CALM with
AP-2. In contrast, no significant colocalization of CALM
with AP-1 was found. Thus, the plasma membrane–coated
pits and vesicles are the main site of localization of CALM in
the cell.
To assess the relative size of the cytosolic and membrane
pools of CALM, we permeabilized the cells mildly with
saponin to allow the release of cytosolic proteins from the
cell. The cytosol (saponin extract) contained only a small
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pool of CALM (5–15%), whereas a large fraction of cellular
CHC (40–60%) was released from permeabilized cells (Fig-
ure 4). The bulk of CALM was associated with the mem-
brane fractions soluble and insoluble in TX100. Interestingly,
the relative distribution of CALM in cellular fractions mir-
rors the distribution of AP-2 but not of AP-1 that is com-
pletely released by TX100 (Figure 4A). The immunofluores-
cence labeling of cells treated with saponin and TX100
reveals the punctate staining of CALM, AP-2 (Figure 4B),
and clathrin (our unpublished data), suggesting that a pool
of plasma membrane–coated pits is resistant to TX100 mem-
brane solubilization.
To estimate the amount of CALM present in different
cellular fractions relative to the amount of CHC, quantitative
Western blot analysis was performed. As standards for im-
munodetection with antibody TD.1 to CHC and Ab20 to
CALM, the GST-fused TD domain of CHC and the fragment
1–413 of CALM, respectively, were used. These quantita-
tions revealed that CALM is present at near stoichiometric
amounts relative to clathrin in TX100-soluble and -insoluble
fractions. Because of the contribution of the components of
TGN-derived clathrin-coated buds to the TX100-soluble
fraction, the molar ratio of CALM to clathrin in endocytic-
coated vesicles present in this fraction could be underesti-
mated. A large pool of components of plasma membrane–
coated vesicles is insoluble in TX100 (Figure 4, A and B)
(references in Woodward and Roth, 1978; Goud et al., 1985).
Therefore, the molar ratio of CALM and clathrin in this
fraction may provide a better estimate of the CALM/CHC
ratio in the plasma membrane–coated pits and vesicles in
vivo. Altogether, the data of Figures 3 and 4 indicate that
CALM is a major component of the endocytic clathrin-
coated pits.
Protein–Protein Interactions of CALM
To determine the major binding partners of CALM, we
labeled HeLa cells metabolically with [35S]methionine and
incubated the cytosolic (saponin-extractable) and membrane
(TX100- and sodium deoxycholate–soluble) fractions of the
cells with GST–CALM immobilized on glutathione-agarose.
The only protein that was specifically bound to GST–CALM
in both cellular fractions has an apparent molecular mass of
;175 kDa (Figure 5A). Western blotting of the same mem-
brane with the anti-CHC revealed that the CHC band pre-
cisely overlaps with the radioactive band (Figure 5A). The
same protein was pulled down from the cytosol by the
C-terminal fragment of CALM, GST–414–652. However,
GST–414–652 did not precipitate CHC from the membrane
fraction (Figure 5B). The N-terminal GST fusion GST–1–413
did not bring down any CHC. These data suggest that
clathrin is the major binding partner of CALM. Binding
involves primarily the C-terminal sequences of CALM, but
the full-length protein is required for the full capacity of
CALM to bind clathrin from cell lysates.
The binding of CALM to Eps15 homology (EH) domains
is predicted because CALM has two NPF motifs (Salcini et
al., 1997; Wendland and Emr, 1998). However, no Eps15 or
Figure 1. Western blotting detection and immunoprecipitation of CALM protein. (A) TX100 lysates of HeLa and COS-1 cells and of COS-1
cells transiently overexpressing CALM (COS-1 1 rCALM) were resolved on 7.5% SDS-PAGE, and CALM was detected by blotting with Ab20.
Molecular weight markers (m.w.m.) are indicated. (B) CALM protein was precipitated with Ab20 from TX100 lysates of HeLa cells, and the
immunoprecipitates (IP) were analyzed by SDS-PAGE and Western blotting with Ab20 to CALM and antibody TD.1 to CHC. Nonspecific
rabbit IgG (NRIgG) was used to control the specificity of immunoprecipitation. (C) The lysates of HeLa cells transfected with GFP fused to
full-length CALM (GFP–CALM) were incubated with anti-GFP, Ab20, or nonspecific IgG, and the immunoprecipitates were analyzed by
electrophoresis and Western blotting with TD.1 or Ab20 to detect CHC or endogenous CALM and GFP–CALM, respectively. The positions
of endogenous 72- and 66-kDa species of CALM and CHC are indicated by arrows. Note, significant overexpression of GFP–CALM (99 kDa)
is indicated by the large arrow. The asterisk marks the proteolytic product of GFP–CALM (;74 kDa). A relatively high amount of the
proteolytic product of GFP–CALM is found in immunoprecipitates, presumably, because of the proteolysis during the immunoprecipitation
procedure.
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Eps15R was detected by Western blotting in GST–CALM or
GST–414–652 precipitates in experiments similar to one
presented in Figure 5. No coimmunoprecipitation of Eps15
and CALM was observed in experiments similar to that
described in Figure 1. Therefore, CALM either does not bind
the EH domains of Eps15 at all or binds these domains very
weakly.
The association of AP-2 with AP180 was observed previ-
ously in in vitro experiments and by coimmunoprecipitation
(Kohtz and Puszkin, 1988; Wang et al., 1995). Small amounts
of a-adaptin (1–2% of the total cellular pool) were pulled
down by GST–CALM and GST–414–652 from the cytosol
and coimmunoprecipitated with CALM in TX100 cell lysates
(our unpublished data).
A putative 65-kDa protein was pulled down from the
cytosol by the GST–414–652 fragment but not by the full-
length CALM. A protein with an apparent mass of 49 kDa
was pulled down from the membrane fraction by GST–
CALM but was not precipitated by its fragments. Bands
corresponding to 48 and 40 kDa were apparently precipi-
tated by the full-length and N-terminal part of CALM (Fig-
ure 5B). The identity of these proteins is unknown. Several
other proteins were found in precipitates of full-length and
nonoverlapping fragments of CALM and likely result from
nonspecific interactions. There was no single band that is
present in all pull-down precipitates containing CHC and is
absent in precipitates of GST–1–413, suggesting that the
interaction of CALM with clathrin is not mediated by an-
other protein.
Cellular Localization of GFP–CALM
To study the distribution of CALM in living cells and to
perform structure–function analysis of CALM, we expressed
GFP–CALM transiently in COS-1 cells. The GFP localization
and the effects of protein expression on the endocytosis of
receptors were analyzed using digital-imaging microscopy.
We have chosen COS-1 cells as the expression system, be-
cause they are easy to transfect, flattened on the plastic
substrate, and are convenient for the light microscopy and
for the measurement of transferrin and EGF receptor inter-
nalization. Figure 6A shows that GFP–CALM is diffusely
distributed within the cytoplasm of living COS-1 cells and is
also associated with small dots clearly seen at the cell pe-
riphery. In addition, there was an accumulation of GFP–
CALM in the juxtanuclear area, typical of the Golgi complex,
that consisted of several bright dots and diffuse fluorescence.
To test whether the punctate fluorescence corresponds to the
clathrin-coated pits and vesicles, double-label immunofluo-
rescence studies were performed on formaldehyde-fixed
cells. When moderately expressed in COS-1 cells, GFP–
CALM is seen in dots throughout the cell and in the Golgi
area and also associated with the edges of the cells (Figure
6B). The cytosolic diffuse fluorescence of GFP–CALM was
less intense than that in living cells, presumably, because of
the loss of GFP–CALM during cell permeabilization. Optical
sectioning and digital deconvolution analysis revealed that
the dots of GFP–CALM were often colocalized with CHC,
suggestive of GFP–CALM localization at the plasma mem-
brane–coated pits (Figure 6). Although CHC and GFP–
CALM were seen accumulated in the same Golgi area, it was
impossible to determine by light microscopy whether GFP–
CALM is colocalized with the clathrin buds in the TGN.
Peripheral diffuse staining and the staining of the cell edges
probably correspond to cytosolic GFP–CALM and GFP–
CALM associated with the plasma membrane. The colocal-
ization of GFP–CALM with AP-2 in plasma membrane–
coated pits was also clearly seen in double-labeled cells (our
unpublished data). When GFP–CALM was highly overex-
pressed, the fluorescence of individual coated pits was dif-
ficult to distinguish on the background of the intense cyto-
solic or membrane fluorescence of GFP–CALM. Transfected
CALM–GFP (GFP is at the C terminus; see Figure 2) and
untagged CALM were found in the same locations as GFP–
CALM (our unpublished data). However, the level of ex-
Figure 2. Schematic representation of CALM and homologous pro-
teins. (A) Depicted are the full-length and the short-form human
CALM (shCALM; 50 residues are deleted), rat AP180, Drosophila mela-
nogaster LAP, Caenorhabditis elegans C32E8.10 (U88308), and yeast
yAP180A. The approximate positions of the regions with the highest
sequence similarity between proteins, corresponding to the CALM
amino acid residues 1–300, 507–533, 539–553, 567–590, and 623–638,
and the internal deletion of residues 420–469 (marked with ∧) because
of the alternative splicing of human CALM are indicated. The number
to the right of each lane represents the total number of residues. (B) The
fragments of CALM expressed as GFP fusion proteins are shown. The
first and the last CALM residues and the position of the GFP moiety
are indicated for each construct. Fragments 1–413 and 414–652 as well
as the full-length CALM were also expressed as GST fusion proteins.
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Figure 3. Localization of CALM in the cell. HeLa cells fixed with methanol (A–C) or methanol/acetone (D–H) were incubated with Ab20
and either X.22 (A–C), AP.6 (D–F), or 100/3 (G and H) monoclonal antibody followed by secondary anti-rabbit and anti-mouse IgG
conjugated with fluorescein or CY3, respectively. The serial optical sections were acquired through the CY3 (red) and FITC (green) channels
and deconvoluted as described in MATERIALS AND METHODS. The fluorescein and CY3 images representing individual optical sections
(thickness of 0.2 mm) were merged (C, F, G, and H) after adjustment of both fluorescence signals to similar levels. The red images in C and
F were shifted to the right by 3 pixels (0.2 mm), relative to green images to allow better visualization of the colocalization. Images in G and
H represent two optical sections of the Z-stack that were acquired 3.6 mm apart. Bars: A–C, D–F, and G and H, 5 mm.
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pression of these proteins was at least a magnitude lower
than the expression level of GFP–CALM. Apparently, the
attachment of GFP to the N terminus stabilizes CALM.
To examine which part of CALM is responsible for target-
ing to clathrin-containing structures, we expressed GFP–1–
413 and GFP–414–652 fragments (Figure 2) in COS-1 cells.
GFP–414–652 displays a similar pattern of distribution in
living and fixed COS-1 cells. Visual inspection of living cells
suggests that the intensity of punctate fluorescence of GFP–
414–652 (Figure 6E) is somewhat lower compared with that
of GFP–CALM (Figure 6A). Figure 6, F–H, shows character-
istic colocalization of GFP–414–652 in the structures con-
taining clathrin. In contrast, the GFP–1–413 fragment is seen
evenly distributed within the cell, with a stronger fluores-
cence signal associated with the areas of “thicker” cyto-
plasm, for instance, in the perinuclear area (Figure 6I). No
Figure 4. The quantitative analysis of CALM and CHC in cellular fractions. (A) The saponin (SAP) and TX100-soluble (TX-100) and
-insoluble (pellet) fractions were obtained from HeLa cells as described in MATERIALS AND METHODS and resolved on SDS-PAGE. CHC,
CALM, a-adaptin, and g-adaptin were detected by Western blotting with antibodies TD.1, Ab20, AC.1, and 100/3, respectively. (B) HeLa cells
grown on coverslips were permeabilized with saponin and TX100 as described in MATERIALS AND METHODS, fixed with methanol/
acetone, and incubated with Ab20 and AP.6 followed by secondary anti-rabbit and anti-mouse IgG conjugated with fluorescein or CY3,
respectively. The serial optical sections were acquired through the CY3 (red) and FITC (green) channels and deconvoluted. The fluorescein
(CALM) and CY3 (AP-2) images representing individual optical sections (thickness of 0.2 mm) were merged, and the red image was shifted
to the right by 3 pixels (0.2 mm) relative to the green image to allow better visualization of the colocalization. Inset (bottom right), high
magnification of a group of coated pits (area indicated by white rectangular box) is shown; the arrow indicates the direction of the shift. The
position of the nucleus is indicated (n). Bar, 5 mm. (C) Various amounts of CALM–1–413 and GST–TD were electrophoresed and blotted with,
correspondingly, Ab20 and TD.1 simultaneously with the blotting of CALM and clathrin in cellular fractions obtained as described in A.
Exemplary curves of the dependence of the chemiluminescence signals on the amount of proteins are presented. Typically, the intensity of
these signals measured by densitometry (see MATERIALS AND METHODS) displayed linear dependence within the range of 1–5 pmol of
the proteins. Arbitrary units (a.u.) represent the optical density units. (D) Various aliquots of HeLa cellular fractions were immunoblotted as
described in A, and the chemiluminescence signals that fit within the linear range of the detection in the same experiments were used to
calculate the mole/mole ratio of CALM and CHC. The data are averaged from four experiments similar to that presented in A. Error bars
represent SDs.
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punctate fluorescence in living cells and no obvious local-
ization of this fragment in the plasma membrane–coated
pits in fixed cells were observed (Figure 6, J–L). Essentially
the same pattern of fluorescence was seen in the cells trans-
fected with GFP alone (our unpublished data).
The fragment 1–413 contains domain 1–300 that is highly
conserved in the AP180 protein family (Figure 2). The cor-
responding fragment of AP180 can bind to clathrin triskel-
ions in vitro (Ye and Lafer, 1995a). The inability of the
fragment 1–413 to be targeted to coated pits (Figure 6) and
to bind clathrin in pull-down experiments (Figure 5) could
be attributable to the GFP or GST moiety at the N terminus
or additional residues 300–413 at the C terminus of the
fragment. Therefore, fragments 1–413–GFP, 1–413, GFP–1–
304, and 1–304–GFP (see Figure 2) were expressed in COS-1
cells. Untagged fragment 1–304 was not used because we do
not have the antibody that recognizes this fragment. All
these fragments displayed a diffuse pattern of staining sim-
ilar to that of GFP–1–413, and none colocalized with AP-2
(our unpublished data). These data indicate that the N-
terminal–conserved domain of CALM is not sufficient for
targeting to the coated pits.
Effects of GFP–CALM Expression on Clathrin-
mediated Receptor Traffic
Because CALM is localized to clathrin-coated pits, we
sought to assess the role of CALM in clathrin-mediated
endocytosis. Specifically, the effect of overexpression of full-
length CALM and its fragments on the uptake of TRF–TR, a
marker of coated pit–dependent internalization, was stud-
ied. Inspection of the population of cells transiently express-
ing GFP–414–652, a fragment that binds clathrin, revealed
that a large proportion of the cells containing high levels of
the fusion protein do not efficiently internalize TRF–TR as
judged by the absence of TRF–TR accumulation in the juxta-
Golgi area and peripheral endosomes (Figure 7, A and B).
Similarly, endosomal TRF–TR was not seen in cells overex-
pressing GFP–CALM. The percent of cells in which endocy-
tosis was inhibited was calculated as described in MATERI-
ALS AND METHODS. Whereas 80 6 7% (SD) of cells
overexpressing GFP–CALM or GFP–414–652 displayed im-
paired endocytosis, this value was 8 6 3% (SD) in cells
expressing low or moderate amounts or not expressing these
proteins. Fragment GFP–1–613 also imposed a dominant-
negative effect on endocytosis. In contrast, there was no
significant effect of overexpression of GFP–1–413 on trans-
ferrin endocytosis (Figure 7, G and H). The expression of
1–413–GFP, GFP–1–303, 1–303–GFP, and 1–413 also did not
affect the endocytosis of TRF–TR. The percent of inhibition
in cells expressing fragments of the N terminus of GFP alone
at the level comparable with that of GFP–CALM was within
the range of 4–20%.
The EGF-activated EGF receptor is also internalized by the
clathrin-mediated pathway, although EGF receptors do not
compete with transferrin receptors for the same saturable
element of the internalization machinery (Warren et al.,
1998). The uptake of the EGF–Texas Red conjugate was
inhibited in COS-1 cells overexpressing GFP–CALM and
GFP–414–652 (our unpublished data). To demonstrate this
effect in an independent quantitative assay, we measured
Figure 5. Binding of clathrin heavy chain to GST–
CALM. GST–CALM, GST–1–413, and GST–414–652
were bound to glutathione-agarose beads and incu-
bated with the cytosolic (saponin extract; A) or mem-
brane (TX100 and deoxycholate extract; B) fractions of
35S-metabolically labeled HeLa cells. Beads alone or
with immobilized GST were used to control for the
nonspecific binding of proteins. The agarose precipi-
tates were resolved via 7.5% SDS-PAGE and transferred
to a nitrocellulose membrane. Top, autoradiographs of
the membranes are presented. The position of a 175-
kDa–labeled band specifically associated with GST–
CALM and GST–414–652 is indicated by arrows. Bot-
tom, the same membranes were probed by Western
blotting with antibody TD.1 to CHC. The detected band
precisely overlapped with the 180-kDa radioactive
band. The blots are from the same experiment. Aster-
isks mark other unidentified bands specifically bound
to the fusion proteins.
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the rates of 125I-labeled EGF internalization in cells tran-
siently transfected with CALM or its fragments. Figure 8
shows that overexpression of full-length GFP–CALM and
GFP–414–652 results in significant inhibition of 125I-labeled
EGF uptake. Because no more than one-half of the cell
population express GFP–CALM or GFP–414–652 at levels
sufficient to block coated-pit endocytosis, the rate of EGF
internalization in cells overexpressing GFP-fused proteins
could be projected to be as low as the minimal internaliza-
tion rate for EGF receptor mutants incapable of clathrin-
dependent internalization (Sorkin et al., 1992). Expression of
GFP–1–413 (Figure 8) or GFP–1–304 (our unpublished data)
did not result in any inhibition of endocytosis compared
with that in the mock-transfected cells. Because the frag-
ments fused with GFP at the C terminus or not tagged did
not express at high levels in a large pool of cells, these
fragments were not tested in the 125I-labeled EGF internal-
ization assay. Together, the data in Figures 7 and 8 demon-
strate that overexpression of CALM or its fragments, con-
taining the clathrin interaction portion, significantly inhibits
receptor-mediated endocytosis.
GFP–CALM and Clathrin in TGN
Clathrin-dependent protein trafficking also occurs at the
TGN. The multilabel fluorescence analysis of clathrin stain-
ing of transfected COS-1 cells showed that in many cells
overexpressing GFP–CALM or GFP–414–652 the normal
aggregation of clathrin immunoreactivity at the TGN is not
seen (Figure 7, C and F). The effect of GFP fusion overex-
Figure 6. The localization of GFP–CALM in living and fixed cells. COS-1 cells were transiently transfected with GFP–CALM (FL; A–D),
GFP–414–652 (CT; E–H), or GFP–1–413 (NT; I–L). (A, E, and I) For living-cell microscopy, cells were grown in microscope chambers, and
the images were acquired through the GFP channel as described in MATERIALS AND METHODS. (B–D, F–H, and J–L) Cells grown on
coverslips were fixed and stained with antibody X.22 to CHC followed by secondary IgGs labeled with Texas Red. The serial optical sections
were acquired through the Texas Red (red) and GFP (green) channels and deconvoluted as described in MATERIALS AND METHODS. The
fluorescein (green) and Texas Red (red) channels were merged (D, H, and L) after adjustment of both fluorescence signals to similar levels.
Yellow indicates the overlap of Texas Red and fluorescein fluorescence. All images comprise an individual optical section. Insets, the
peripheral regions of the cells indicated by white square boxes are shown at higher magnification and with enhanced contrast. Bar, 5 mm.
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pression on TGN-associated clathrin correlated well with
the inhibition of TRF–TR endocytosis. In contrast, GFP–1–
413 did not redistribute clathrin from the TGN (Figure 7H).
The localization of clathrin in cells overexpressing GFP–
CALM is shown in more detail in Figure 9, A and B. In many
cells the dispersion of the TGN-associated clathrin staining
Figure 7. The effect of GFP–CALM overexpression on transferrin endocytosis and clathrin distribution. COS-1 cells expressing GFP–414–
652 (CT; A–C), GFP–CALM (FL; D–F and J–L), or GFP–1–413 (NT; G–I) were incubated with 5 mg/ml TRF–TR for 15 min at 37°C, fixed, and
stained with antibodies X.22 to CHC (A–I) or 100/3 to g-adaptin (J–L) followed by secondary IgGs labeled with AMCA. The serial optical
sections were acquired through the Texas Red (red), GFP (green), and AMCA/DAPI (blue) channels and deconvoluted as described in
MATERIALS AND METHODS. All images represent the merged images of 20 serial optical sections (total thickness of 4 mm). The
approximate perimeter of GFP-expressing cells is indicated in the images of TRF–TR endocytosis by the dashed lines (B, E, H, and K). Bar,
5 mm.
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was coincident with the appearance of large structures con-
taining clathrin in the perinuclear area.
The release of clathrin from the TGN did not appear to
disrupt the TGN-associated accumulation of GFP–CALM or
GFP–414–652 in the TGN area. Importantly, the overexpres-
sion of these proteins did not lead to redistribution of AP-1
from the TGN (Figure 7, J–L). These data suggest that the
integrity of the TGN is not affected by GFP–CALM overex-
pression whereas the recruitment of clathrin to TGN mem-
branes and the clathrin–AP-1 interactions are abrogated.
To assess whether the dramatic loss of clathrin from the
TGN membranes affects the protein traffic through TGN-
coated pits, we inspected the subcellular distribution of the
cation-independent M6P receptor, which uses the clathrin-
mediated pathway from the TGN to endosomes (Traub and
Kornfeld, 1997). Immunofluorescence staining of COS-1 cells
detected most M6P receptors in large endosome-like or-
ganelles in the perinuclear area and a small pool of receptors
in the TGN. Interestingly, overexpression of GFP–CALM
significantly diminished the endosomal staining of the M6P
receptor (Figure 9, C and D), suggesting that receptor move-
ment from the TGN and presumably the cell surface to
endosomes is inhibited. A similar effect was observed in
cells overexpressing GFP–414–652 (Figure 9, E and F),
whereas GFP–1–413 did not have any effect on M6P receptor
localization (our unpublished data). Taken together, the data
presented in Figures 7–9 demonstrate that overexpression of
the clathrin-binding fragment of CALM or full-length
CALM impairs two major clathrin-mediated trafficking pro-
cesses occurring at the cell surface and at the TGN. Thus,
GFP–CALM and its fragments may serve as useful tools for
comparative studies of the role of clathrin in the trafficking
of the variety of the proteins, lipids, and viruses at the cell
surface and TGN as well as in other compartments such as
endosomes and secretory granules.
Interactions of CALM with Clathrin In Vivo
The effect on receptor endocytosis and clathrin–AP-1 inter-
action at the TGN can be explained if the overexpression of
GFP–CALM or its C-terminal portion disrupted the protein–
protein interactions involved in clathrin vesicle formation.
Our results show that clathrin is the major CALM-binding
partner. To test whether GFP–CALM expressed in COS-1
cells forms complexes with clathrin retained during cell
solubilization, a coimmunoprecipitation assay was used.
GFP–CALM and CHC were immunoprecipitated from
TX100 cell lysates with anti-GFP and anti-CHC (X.22) anti-
bodies, respectively. GFP and CHC were then probed in the
immunoprecipitates by Western blotting (Figure 10A). Both
reciprocal coimmunoprecipitations indicated the presence of
GFP–CALM–CHC complexes. The pools of CALM and CHC
insoluble in TX100 could be released by sodium deoxy-
cholate (1%). However, deoxycholate treatment resulted in a
poor immunoprecipitation efficiency of anti-GFP and abol-
ished the interaction of CALM fragment GST–413–652 with
CHC in vitro (Figure 5 and our unpublished data). There-
fore, we were not able to determine the extent of CHC–
CALM association in the TX100-insoluble fraction.
To map the region of CALM involved in the interaction
with CHC, we expressed various parts of CALM as GFP
fusion proteins in COS-1 cells. Immunoprecipitation with
anti-GFP revealed that CHC is significantly bound to GFP–
413–652 but not to GFP–1–413 (Figure 10B). The smaller
fragments of the N terminus such as GFP–1–304 (Figure 10B)
and 1–304–GFP (our unpublished data) also did not coim-
munoprecipitate CHC.
The ability of GFP–414–652 to bind clathrin correlated
with its inhibitory effect on clathrin-mediated trafficking
(Figures 7–9). Two parts of the C terminus, GFP–414–613
and GFP–613–652 (Figure 2), each containing sequences
highly homologous to rat brain AP180, were expressed in
COS-1 cells, and their ability to interact with CHC was
examined using coimmunoprecipitation. Figure 10B shows
that neither fragment was associated with clathrin to a sig-
nificant extent, although clathrin binding of the GFP–414–
613 fragments was detected in several experiments. These
data suggest that both regions are necessary for the efficient
interaction of GFP–414–652 with CHC. Surprisingly, the
large fragment of CALM, GFP–1–613 (see Figure 2) that
Figure 8. Internalization of 125I-labeled EGF in GFP–CALM–ex-
pressing cells. (A) COS-1 cells transfected with GFP (mock; E),
GFP–CALM (), GFP–414–652 (), or GFP–1–413 (F) were incu-
bated with 2.0 ng/ml 125I-labeled EGF for 1–10 min, and the amount
of surface-bound and internalized radioactivity was determined as
described in MATERIALS AND METHODS. The rate of internal-
ization is expressed as the ratio of internalized and surface 125I-
labeled EGF for each time point. (B) Internalization rates are aver-
aged from four experiments performed as described in A. The rates
are expressed as the percent of internalization rates in mock-trans-
fected cells.
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lacks the fragment 614–652, could efficiently coimmunopre-
cipitate CHC (Figure 9B). This result suggests that in the
presence of the N-terminal portion of CALM, the small
region 614–652 is not required for the interaction with clath-
rin. It should be noted that the absolute amounts of coim-
munoprecipitated CHC and GFP–CALM or its fragments
varied in different experiments because of variability in the
transfection efficiencies and the resulting cytosol/membrane
distribution of GFP-fused proteins.
Overall, the ability of GFP fusion fragments of CALM to
bind clathrin strongly correlated with their localization in
clathrin-coated pits and vesicles and with the inhibitory
effect on endocytosis when overexpressed. In all assays,
full-length CALM displayed the highest capability to bind
clathrin. Together, the data of GST pull-down and coimmu-
noprecipitation experiments suggest that CALM has several
clathrin-binding interfaces and that possibly two of them are
located within the C-terminal region 414–652.
DISCUSSION
The experiments performed in this study provide the first
characterization of the biochemical and functional proper-
ties of CALM, a new component of the clathrin coat in
nonneuronal cells. CALM is homologous to the brain-spe-
cific protein AP180, and the rationale of many experiments
in this study was based on what is known about AP180.
Figure 9. The effect of GFP–CALM expres-
sion on the localization of clathrin and M6P
receptor. COS-1 cells expressing GFP–CALM
(FL; A–D) or GFP–414–652 (CT; E and F)
grown on coverslips were fixed and stained
with mouse monoclonal anti-clathrin X.22 (A
and B) and rabbit polyclonal anti-M6P recep-
tor (C–F) followed by the secondary goat
IgGs specific to mouse or rabbit IgG, respec-
tively, labeled with Texas Red. The serial op-
tical sections were acquired through the
Texas Red (red) and GFP (green) channels
and deconvoluted as described in MATERI-
ALS AND METHODS. Images represent the
merged images of two serial optical sections
(total thickness of 0.4 mm) from the middle of
the cell, where the most intense signal for
CHC or M6P receptor (M6P-R) in the perinu-
clear area was observed. Asterisks show the
position of cell nuclei. Bars: A and B, C and D,
and E and F, 10 mm.
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Immunofluorescence labeling of CALM revealed the pres-
ence of this protein in all detectable coated pits at the cell
surface, suggesting that CALM may play a role in a general
step of clathrin-mediated endocytosis. CALM is coimmuno-
precipitated with clathrin (CHC) in cell lysates and binds
CHC in pull-down experiments. In the cell, CALM is present
in a lower molar amount than is CHC. However, whereas a
large pool of clathrin is found in the cytosol, the bulk of
CALM is associated with the membrane and the detergent-
insoluble fractions of the cell where it is present at near
stoichiometric amounts relative to CHC. We suggest that the
molar ratio of CHC to CALM in the TX100-insoluble fraction
approximately corresponds to this ratio in plasma mem-
brane–coated pits and vesicles. First, surface-coated pits
appear to be the main and probably the only site of CALM
localization in the cell. A pool of endocytic-coated pits and
vesicles is resistant to TX100 extraction, whereas the major-
ity of membrane-associated proteins including AP-1 are re-
leased by this detergent (Figure 4) (references in Woodward
and Roth, 1978; Goud et al., 1985). The punctate staining of
AP-2 and clathrin remains clearly visible in cells treated with
TX100 (Figure 4), whereas no AP-1 and clathrin are seen
accumulated in the Golgi area (our unpublished data). A
molar ratio of 1:1 was determined previously for AP180 and
CHC in the brain-derived coated vesicle preparations. Thus,
AP180 and/or CALM together with AP-2 and clathrin may
be the structural elements of plasma membrane coats in
neuronal and nonneuronal cells.
Studies of AP180 have described the clathrin-binding and
coat-assembly activities of this protein in vitro in detail,
although the mechanism of AP180 binding to clathrin re-
mains unclear. Apparently, both N-terminal (33 kDa) and
C-terminal (55 kDa) parts of AP180 have clathrin-binding
activity (Ye and Lafer, 1995a,b). The N-terminal domain of
AP180 is almost identical to the corresponding region of
CALM that is also important for the full clathrin-binding
capacity of CALM (Figure 10B). However, our data indicate
that N-terminal fragments of CALM do not bind CHC in cell
lysates and are not targeted to clathrin-coated pits regardless
of whether the tag is at the N- or the C terminus or the
fragment is not tagged. These data suggest that the potential
ability of the 1–303 fragment to bind clathrin triskelions in
vitro is not sufficient for interaction with clathrin in cell
lysates, targeting to coated pits, and the dominant-negative
effect on endocytosis. In contrast, the GFP-tagged C-terminal
portion of CALM (residues 413–652 corresponding to the
last 27-kDa portion of AP180) coimmunoprecipitates with
clathrin under mild conditions and is localized to plasma
membrane–coated pits. The important role of the C termi-
nus of CALM in binding to clathrin is supported by the
observation that yeast YAP180 binds to clathrin also via the
C-terminal domain (Wendland and Emr, 1998).
It can be suggested that multiple interfaces participate in
CALM–CHC interactions. At least two hydrophobic
stretches within the C-terminal portion of CALM display
high homology to rodent AP180 and could be responsible
Figure 10. Coimmunoprecipitation of CHC with CALM and its fragments. (A) The lysates of COS-1 cells transfected with GFP–CALM were
incubated with anti-GFP, X.22, or nonspecific mouse IgG (mIgG), and the immunoprecipitates were resolved by SDS-PAGE. CHC and
GFP–CALM were detected by blotting with TD.1 or anti-GFP, respectively. (B) GFP–CALM, GFP–414–652, GFP–1–413, GFP–1–304,
GFP–1–613, GFP–414–613, and GFP–613–652 fragments (see Figure 2) were immunoprecipitated with anti-GFP from the TX100 lysates of
transiently transfected COS-1 cells. The immunoprecipitates were analyzed by SDS-PAGE, and the presence of CHC and GFP fusion proteins
in the immunoprecipitates was detected by blotting with antibodies TD.1 or anti-GFP, respectively. Arrows indicate the positions of the GFP
fusion proteins, whereas the arrowheads point to the position of CHC. The lanes in each panel (labeled Exp1, Exp2, and Exp3) are from the
same experiment. The data in each panel are representative of several independent experiments.
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for binding to CHC. However, the molecular details of the
binding of CALM and/or AP180 and other proteins to CHC
remain to be elucidated. A putative sequence consensus L
(L, I) (D, E, N) (L, F) (D, E) has been suggested to participate
in the protein binding to the TD domain of CHC
(Dell’Angelica et al., 1998). However, it is unlikely that this
sequence is a general clathrin-binding consensus and is suf-
ficient for the interaction with the TD domain. For instance,
both nonvisual arrestins and AP-2 have this motif but do not
compete for binding to the TD domain (Goodman et al.,
1997). The sequence LLDL (393–396), which resembles this
clathrin-binding consensus, is situated within the 1–413
fragment that is incapable of interaction with clathrin in cell
lysates (Figures 5 and 10). Although detailed mutagenesis
studies are necessary to map precisely the sequence motifs
involved, it is possible that the presence of at least two
binding sites is required for stable interaction of CALM with
clathrin. For instance, in the absence of the binding site in
the fragment 613–652, the sequence(s) located in the N-
terminal fragment 1–413 is required for clathrin binding of
the fragment GFP–1–613 (Figure 10). On the other hand, two
or more sites of interactions within the 414–652 fragment
are sufficient for binding to CHC. It is also possible that all
binding activity is located within the fragment 414–613, but
the folding of this fragment fused to GFP does not allow its
proper binding to CHC. In all types of assay, the full-length
CALM displayed the greatest ability to localize to clathrin-
containing organelles and to bind clathrin, consistent with
the additivity of the clathrin-binding motifs.
The mechanism of the specific targeting of endogenous
CALM to the plasma membrane is unclear. Binding to clath-
rin cannot be sufficient for this targeting because clathrin is
present in other cellular organelles. In fact, when GFP–
CALM is expressed at high levels, it is found in the Golgi
area and cytosol in addition to its normal localization at the
plasma membrane. It is possible that endogenous CALM is
selectively recruited to the plasma membrane–coated pits
via binding to AP-2. CALM has one DPF sequence within
the fragment 414–652 (residues 420–422). DPF and DFW
motifs have been implicated in the interaction with the C
terminus of the a-subunit of AP-2 (Chen et al., 1998). How-
ever, in our experiments very little AP-2 was detected in
CALM immunoprecipitates and pull-downs. This pool of
AP-2 could be bound to CALM indirectly via clathrin. It is
also possible that DPF-based interactions are not strong
enough to survive the conditions of our binding assays.
Although the interaction of AP180 with a-adaptin was ob-
served in vitro (Wang et al., 1995), DPF motifs are not con-
served in CALM homologous proteins. Therefore, it is un-
likely that DPF–AP-2 interactions determine the localization
of CALM in endocytic-coated pits. Another hypothetical
possibility is that CALM can selectively interact with the
plasma membrane–associated cytoskeleton or lipids.
Despite the presence of two NPF motifs, no interaction of
CALM with Eps15 or Eps15R was detected in the GST
pull-down and coimmunoprecipitation experiments. Be-
cause the NPF–EH interaction affinity is low (De Beer et al.,
1998), the CALM–EH complex may not be detectable in
conventional protein–protein interaction assays. Denatured
GST–CALM or GST–414–652 can bind the recombinant EH
domains of Eps15 in a far Western assay (our unpublished
data). The possibility exists that the localization of these
proteins in close proximity in coated pits may allow a sig-
nificant increase of local concentrations of EH domains and
CALM, thus leading to the stable interaction of these pro-
teins. It is also possible that CALM can bind to the EH
domains of proteins other than Eps15, for instance to inter-
sectin (Yamabhai et al., 1998).
In summary, we identified only one interaction partner of
CALM, the clathrin heavy chain. Whereas clathrin is prob-
ably the major interactor of the C-terminal domain of
CALM, identification of binding partners for the conserved
N-terminal domain is important for the elucidation of
CALM function. However, analysis of CALM interactions in
coated pits is difficult because the large pool of the mature
clathrin-coated pits is insoluble under mild conditions. Sol-
ubilization in the presence of ionic detergents like sodium
deoxycholate or high concentrations of salts dramatically
weakens the interaction of CALM with clathrin (Figure 5)
and probably other molecules.
Overexpression of GFP–CALM caused inhibition of endo-
cytosis and disrupted clathrin localization in the TGN, thus
affecting TGN–endosome trafficking. These two effects may
have similar or different mechanisms. Endogenous CALM is
located only in endocytic-coated pits. Therefore, the local-
ization of GFP–CALM in the Golgi area and the effects of
CALM on TGN may not be related to CALM function.
Apparently, CALM prevents the recruitment of clathrin to
the membrane-associated AP-1, which results in mistarget-
ing clathrin. This could be the result of the competition for
binding to CHC between CALM and AP-1. In contrast,
overexpression of GFP–CALM or its clathrin-binding frag-
ments did not cause any visible mistargeting effect on
plasma membrane clathrin. Apparently, clathrin/AP-2 coats
are more stable than clathrin/AP-1 coats. The stability of
plasma membrane–coated pits can be illustrated by their
resistance to detergent solubilization. CALM may have mul-
tiple binding sites on the CHC molecule as shown for AP180
(Murphy and Keen, 1992), and the association of an addi-
tional CALM with CHC may disrupt interactions of other
proteins with clathrin within the preformed coat. Thus, the
amount of CALM relative to that amount of clathrin and
other components of coated pits might be an important
regulator of the endocytosis process. A recent report describ-
ing the effect of knock-out of LAP in Drosophila implicates
proteins of the CALM and/or AP180 family in the regula-
tion of the size of the coated vesicles (Zhang et al., 1998). By
interacting with several sites of CHC, CALM can regulate
the curvature of the coat and, therefore, the size of the
budding vesicle. Future ultrastructure studies should deter-
mine whether overexpression of CALM affects the size of
coated pits and vesicles in mammalian cells.
Thus, CALM may participate in the formation of the clathrin
vesicle by regulating the interactions involving the TD and
possibly other domains of CHC. Obviously, alternative models
of CALM function can be proposed. For instance, CALM can
potentially associate with phosphatidylinositols (Hao et al.,
1997) and provide an additional force for the recruitment of
clathrin to the membrane. Finally, CALM may serve as an
adaptor for recruitment of proteins into the coated pit. In this
case the C-terminal domain of CALM would bind to the TD
domain of CHC, whereas the N terminus of CALM would
interact with the intracellular tail of cargoes.
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